Aesthetic and semanticaccents of the neo-gothic interpretation in Russia

The relevance of the work is due to the need for a strategy of reconstruction of historic exterior and interior of architectural object located in a ruin condition with very limited factual information. The article considers specific features of the evolution of the neo-Gothic in the late XIX – early XX centuries in Russia. The stylistic unity of the neo-Gothic and the Modern is traced. Special attention is paid to the principles of a reconstruction of the lost elements of architecture and interior design in theneo-Gothic style. The estate in the neo- Gothic style is the harmonious union of separate elements into a unified aesthetic whole. The principle of the unification is the harmony between carefully designed and comfortable environment and its decorative design. Stylistic tolerance in the approach to the creation of a unified subjective and spatial environment that combines aesthetic and semantic components of such styles as Gothic, Renaissance, Baroque, etc. is revealed. The approaches to the interpretation of the neo-Gothic architectural object is defined on the example of creative work of the master P. C. Boytsov (1849-after 1918), specialized in the creation of the estates and their interiors. The proposed guidelines for the reconstruction are given on the example of the proposal of reconstruction of the neo-Gothic interiors of several ensembles of P. S. Boytsov.Keywords: Neo-Gothic, Modern, estate, the Modern architecture, the reconstruction of the historic interior, the interior in the Modern style, interpretatio

Сравнительная клиническая эффективность лекарственных средств неспецифической профилактики гриппа и орви у детей в период сезонного подъема заболеваемости

Objective: comparative open-label randomized study of the safety and efficacy of the drugs Alpha-glutamyl-tryptophan + Ascorbic acid + Bendazole («Cytovir-3«) and Umifenovir for prophylactic influenza and acute respiratory viral infectionsin children aged over 6 in organized groups.Materials and methods. 207 healthy children ≥6 years old of organized educational groups. According to study protocol they were divided into 2 groups: 102 children were randomizes to receive Alpha-glutamyl-tryptophan + Ascorbic acid + Bendazole (Сytovir-3, Group 1), capsules (JSC MBSPC «Cytomed«, Russia) while 105 children were randomizes to receive Umifenovir 100 mg (Group 2) capsules (Pharmstandart Leksredstva, Russia). The frequency of adverse reactions on drugs and adverse events was assessed while taking drugs and within 3 weeks after. Efficiency was assessed by calculate value of prophylactic efficiency index in comparison groups. Efficacy was analyzed on the basis of the comparative incidence of children included in the study with a total incidence in Saint-Petersburg.Results: the studied drugs showed a high safety profile and match preventive clinical efficacy against influenza and acute respiratory viral infections. Both drugs during prophylactic administration stimulated the production of secretory IgA. A tendency to a decrease in the incidence of acute respiratory viral infections in groups of children taking the studied drugs was revealed and compared with general indicators reflecting the integrated epidemic situation of influenza and other acute respiratory viral infections in Saint-Petersburg during the study. The data obtained allow us to recommend the use of the drug Alpha-glutamyl-tryptophan + Ascorbic acid + Bendazole («Сytovir-3«) (dosage form – capsules) for the prevention of respiratory diseases in organized children’sgroups during the period of seasonal increase in the incidence of  influenza and acute respiratory viral infectionsin.Цель: открытое сравнительное, рандомизированное исследование безопасности и эффективности препаратов Альфа-глутамил-триптофан + Аскорбиновая кислота + Бендазол («Цитовир-3») и «Умифеновир» для профилактики гриппа и ОРВИ у детей с 6 лет в организованных коллективах.Материалы и методы. В исследовании приняли участие 207 детей в возрасте ≥6 лет соматически здоровые, посещающие организованные образовательные коллективы. Согласно протоколу исследования, дети были рандомизированы на 2 группы: 1-я (n=102) получала препарат Альфа-глутамил-триптофан + Аскорбиновая кислота + Бендазол («Цитовир-3»), капсулы (ЗАО «МБНПК «Цитомед», Россия), 2-я группа (n=105) – «Умифеновир» капсулы 100 мг («Фармстандарт Лексредства», Россия). Оценивалась частота побочных реакций на препараты и нежелательных явлений на фоне приема лекарственных средств и в течение 3 недель после. Профилактическая эффективность оценивалась путем расчёта величины – индекс эффективности, определения sIg A, а также на основании сравнительной заболеваемости детей, включенных в исследование с общей заболеваемостью в Санкт-Петербурге.Результаты: исследуемые препараты показали высокий профиль безопасности и  соответствующую клиническую эффективность по предупреждению гриппа и ОРВИ. Оба препарата на фоне профилактического приема стимулировали выработку секреторного IgA. Выявлена тенденция к снижению заболеваемости ОРВИ в группах детей, принимавших исследуемые препараты, в сравнении с общими показателями, отражающими интегральную эпидемическую ситуацию по гриппу и другим ОРВИ в Санкт-Петербурге во время  проведения исследования. Полученные данные позволяют рекомендовать применение  препарата Альфа-глутамил-триптофан + Аскорбиновая кислота + Бендазол («Цитовир-3») (лекарственная форма – капсулы) для профилактики респираторных заболеваний в организованных образовательных детских коллективах в период сезонного повышения заболеваемости

РОЛЬ БИОБАНКОВ В ИЗУЧЕНИИ ПОПУЛЯЦИОННОГО ИММУНИТЕТА

Review focuses on estimation of population immunity and  effectiveness of vaccination against socially significant influenza  infection. Long-term observations of the population immunity,  including post-vaccine seroprevalence to influenza are an important  component of surveillance. The possibility of use of systems of  biological banks (biobanks) in these investigations is of great  interest. The data on the principles of biobanks design in the world,  the scope of their application, the present state of the industry are  described. The information about collections of infectious diseases  agents is presented. Suggestions to build a network of biobanks in the Russian Federation and its implementation in the system of  epidemiological influenza surveillance are formed. The biobanks  filling by samples, principles of selection of donors biological  specimens, methods of laboratory research are discussed.Обзор посвящен оценке популяционного иммунитета и эффективности вакцинации против  грипп. Многолетние наблюдения за коллективным (популяционным) иммунитетом, включая  поствакцинальный, при гриппе остаются важной составляющей эпидемиологического надзора. Новые возможности в исследовании популяционного  иммунитета открываются с созданием системы биологических банков (биобанков).  Приводятся данные по принципам построения биобанков в мире, сферы их применения,  современное состояние данной отрасли. Представлены сведения о коллекциях возбудителей инфекционных заболеваний. Даны предложения по построению сети  биобанков в Российской Федерации с внедрением в систему эпидемиологического надзора  за вирусными заболеваниями. Обсуждается структура наполняемости биобанков образцами, принципы подбора доноров биологических образцов,  методы их лабораторного изучения

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU

Abstract. Evaluation of reactogenicity, safety and immunogenicity of the inactivated subunit influenza vaccine adsorbed monovalent (Pandeflu) on the base of strain A/California/7/2009 (H1N1v) was conducted in 70 volunteers aged 18–60 years immunized by one or two doses. A clinical trial of the vaccine Pandeflu was conducted in the St.Petersburg Institute of Influenza. The study group included 38 women (54,3%) and 32 men (45,7%). The average age of women was 38.2 years, men — 26.9 years, mean age of all volunteers was equal to 31.7 years. This group of volunteers was randomized in 2 subgroups. The first subgroup of 50 volunteers was vaccinated with Pandeflu, but the second one of 20 volunteers was given a placebo. The strong and moderate local and systemic reactions were not observed. All local (6 volunteers) and systemic (6 volunteers) reactions were recorded after ithout any medical care. It proves the good tolerability and low reactogenicity of vaccine Pandeflu. Indicators of clinical and biochemical blood tests, a general analysis of urine during the study period were within normal limits. In the study of the immunogenicity it has been shown that after a single injection of vaccine the first vaccination. All these reactions were mild and transient and disappeared wPandeflu the seroconversion rate reached 68%, but the level of seroprotection was 52%. The multiplication factor of the geometric mean antibody titer increase in serum reached a value of 5.8. Conducting of immunization with two doses of vaccine with the interval of 28 days increases the immunogenicity: the level of seroconversion rate increases up to 96%, but the level of seroprotection – up to 74%, seroconversion factor – up to 10.8. These data confirm high immunogenic potential vaccine in case of single dose as well as double doses administration

Ультразвуковое исследование при планировании операций по поводу меланомы кожи конечностей

We performed a retrospective analysis of ultrasound scans in 42 patients with cutaneous melanoma of the extremities in planning the closure of skin defects with skin fascial island flaps supplied by perforating vessels. First, the primary melanoma focus was scanned by ultrasound to reveal characteristics of the skin, tumor and adjacent tissues. Then we detected perforating vessels to mark them and to select the sites for the island flaps. Ultrasound examination was performed using the IU 22 PHILIPS, GE Logiq E9 and Supersonic imagine AIxPLORER MultiWave Systems with linear multi-frequency sensors (517 MHz) in the B-mode, color and power Doppler to visualize the blood flow. We clarified the criteria of the necessary and sufficient parameters according to Doppler ultrasound visualization for surgical treatment of cutaneous melanoma of the extremities by the suggested method in preoperative period, as well as monitoring of the flap state after surgery. The transfer of flaps on perforating vessels did not cause blood flow disorders in them: the mean arterial blood flow velocity was 13.1 ± 4.7 cm/sec before surgery and 12.8 ± 5.4 cm/sec after it. The maximal venous flow velocity was on average 7.0 ± 1.3 cm/sec before surgery and 6.2 ± 0.8 cm/sec after it. Thus, triplex ultrasound significantly facilitates the selection and individual design of the flap with the inclusion of feeding vessels of sufficient potential, helps in planning the operation, reduces the risk of failure and improves the results of treatment. This method contributes to the radicalization of surgical intervention with a simultaneous decrease in the risk of postoperative complications and acceleration of medical and social rehabilitation of patients.Проведен ретроспективный анализ ультразвуковых исследований у 42 больных меланомой кожи конечностей при планировании закрытия кожного дефекта островковыми кожно-фасциальными лоскутами на перфорантных сосудах. Вначале выполнялось УЗИ первичного очага меланомы для уточнения характеристик кожи, опухоли, прилежащих тканей. Затем осуществлялся поиск перфорантных сосудов для их маркировки и определения расположения островковых лоскутов. УЗИ выполнены на экспертных аппаратах «IU 22 PHILIPS», GE «Logiq E9», «Supersonic imagine AIxPLORER multi Wave» линейными мультичастотными датчиками (5–17 мГц) в В-режиме, цветовом и энергетическом картировании кровотока. Уточнены критерии необходимых и достаточных параметров по результатам сонодопплерографической визуализации для хирургического лечения меланомы кожи конечностей по предлагаемому способу в предоперационном периоде и мониторинг состояния лоскутов после операции. Было установлено, что перемещение лоскутов на перфорантных сосудах не приводило к нарушениям кровотока в них: до операции средняя скорость артериального кровотока составила 13,1±4,7 см/с, после операции – 12,8±5,4 см/с. Максимальная венозная скорость до операции в среднем была 7,0±1,3 см/с, после операции – 6,2±0,8 см/с. Таким образом, триплексное сканирование значительно облегчает выбор и индивидуальный дизайн лоскута с включением в него питающих сосудов достаточного потенциала, существенно помогает в планировании операции, снижет риск неудач и способствует улучшению результатов лечения. Данный метод способствует повышению радикальности хирургического вмешательства с одновременным снижением риска послеоперационных осложнений, ускорением медицинской и социальной реабилитации больных

Characterisation of a Novel White Laccase from the Deuteromycete Fungus Myrothecium verrucaria NF-05 and Its Decolourisation of Dyes

A novel ‘white’ laccase was purified from the deuteromycete fungus, Myrothecium verrucaria NF-05, which was a high laccase-producing strain (40.2 U·ml−1 on the thirteenth day during fermentation). SDS-PAGE and native-PAGE revealed a single band with laccase activity corresponding to a molecular weight of approximately 66 kDa. The enzyme had three copper and one iron atoms per protein molecule determined by ICP-AES. Furthermore, both UV/visible and EPR spectroscopy remained silence, indicating the enzyme a novel laccase with new metal compositions of active centre and spectral properties. The N-terminal amino acid sequence of the purified protein was APQISPQYPM. Together with MALDI-TOF analysis, the protein revealed a high homology of the protein with that from reported M. verrucaria. The highest activity was detected at pH 4.0 and at 30°C. The enzyme activity was significantly enhanced by Na+, Mn2+, Cu2+ and Zn2+ while inhibited by DTT, NaN3 and halogen anions. The kinetic constant (Km) showed the enzyme was more affinitive to ABTS than other tested aromatic substrates. Twelve structurally different dyes could be effectively decolourised by the laccase within 10 min. The high production of the strain and novel properties of the laccase suggested its potential for biotechnological applications

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)

Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials and methods. 3169 patients with AF were enrolled in outpatient RECVASA (Ryazan), RECVASA AF-Yaroslavl registries and hospital RECVASA AF (Moscow, Kursk, Tula). 2497 (78.8%) registries of patients with AF had CAD and 703 (28.2%) of them had a previous myocardial infarction (MI).Results. There were 2,497 patients with a combination of AF and CAD (age was 72.2±9.9 years; 43.1% of men; CHA2DS2-VASc – 4.57±1.61 points; HAS-BLED – 1.60±0,75 points), and the group with AF without CAD included 672 patients (age was 66.0±12.3 years; 43.2% of men; CHA2DS2-VASc – 3.26±1.67 points; HAS-BLED – 1,11±0.74 points). Patients with CAD were on average 6.2 years older and had a higher risk of thromboembolic and hemorrhagic complications (p<0.05). 703 patients with a combination of AF and CAD had the previous myocardial infarction (MI; age was 72.3±9.5 years; 55.2% of men; CHA2DS2-VASc – 4.57±1.61; HAS-BLED – 1.65±0.76), and 1794 patients didn't have previous MI (age was 72.2±10.0 years; 38.4% of men; CHA2DS2-VASc – 4.30±1.50; HAS-BLED – 1.58±0.78). The proportion of men was 1.4 times higher among those with the previous MI. Patients with a combination of AF and CAD significantly more often (p <0.0001) than in the absence of CAD received a diagnosis of hypertension (93.8% and 78.6%), chronic heart failure (90.1% and 51.2%), diabetes mellitus (21.4% and 13.8%), chronic kidney disease (24.8% and 17.7%), as well as anemia (7.0% and 3.0%; p=0.001). Patients with and without the previous MI had the only significant difference in the form of a diabetes mellitus higher incidence having the previous MI (27% versus 19.2%, p=0.0008). The frequency of proper cardiovascular pharmacotherapy was insufficient, mainly in the presence of CAD (67.8%) than in its absence (74.5%), especially the prescription of anticoagulants (39.1% and 66.2%; p <0.0001), as well as in the presence of the previous MI (63.3%) than in its absence (74.3%). The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death (risk ratio [RR]=1.58; 95% confidence interval [CI] was 1.33-1.88; p <0.001 and RR=1.59; 95% CI was 1.33-1.90; p <0.001), as well as with a higher risk of developing a combined cardiovascular endpoint (RR=1.88; 95% CI was 1.17-3 , 00; p <0.001 and RR=1.75; 95% CI was 1.44-2.12; p<0.001, respectively).Conclusion. 78.8% of patients from AF registries in 5 regions of Russia were diagnosed with CAD, of which 28.2% had previously suffered myocardial infarction. Patients with a combination of AF and CAD more often than in the absence of CAD had hypertension, chronic heart failure, diabetes, chronic kidney disease and anemia. Patients with the previous MI had higher incidence of diabetes than those without the previous MI. The frequency of proper cardiovascular pharmacotherapy was insufficient, and to a greater extent in the presence of CAD and the previous MI than in their absence. All-cause mortality was recorded in patients with a combination of AF and CAD more often than in the absence of CAD. All-cause mortality and the incidence of nonfatal myocardial infarction were higher in patients with AF and the previous MI than in those without the previous MI. The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death, as well as a higher risk of developing a combined cardiovascular endpoint

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes

Aim. To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial fibrillation (AF) and chronic heart failure (CHF) based on prospective registries of patients with cardiovascular diseases (CVD).Materials and Methods. The data of 3795 patients with atrial fibrillation (AF) were analyzed within the registries RECVASA (Ryazan), RECVASA FP (Moscow, Kursk, Tula, Yaroslavl), REGION-PO and REGION-LD (Ryazan), REGION-Moscow, REGATA (Ryazan). The comparison groups consisted of 3016 (79.5%) patients with AF in combination with CHF and 779 (29.5%) patients with AF without CHF. The duration of prospective observation is from 2 to 6 years.Results. Patients with a combination of AF and CHF (n=3016, age was 72.0±10.3 years; 41.8% of men) compared with patients with AF without CHF (n=779, age was 70.3±12.0 years; 43.5% of men) had a higher risk of thromboembolic complications (CHA2DS2-VASc – 4.68±1.59 and 3.10±1.50; p<0.001) and hemorrhagic complications (HAS-BLED – 1.59±0.77 and 1.33±0.76; p<0.05). Patients with a combination of AF and CHF significantly more often (p<0.001) than in the absence of CHF were diagnosed with arterial hypertension (93.9% and 83.8%), coronary heart disease (87.9% and 53,5%), myocardial infarction (28.4% and 14.0%), diabetes mellitus (22.4% and 7.7%), chronic kidney disease (24.8% and 16.2%), as well as respiratory diseases (20.1% and 15.3%; p=0.002). Patients with AF in the presence of CHF, compared with patients without CHF, were more often diagnosed with a permanent form of arrhythmia (49.3% and 32.9%; p<0.001) and less often paroxysmal (22.5% and 46.2%; p<0.001) form  of  arrhythmia.  Ejection  fraction  ≤40%  (9.3%  and  1.2%;  p<0.001),  heart  rate  ≥90/min  (23.7% and 19.3%; p=0.008) and blood pressure ≥140/90 mm Hg (59.9% and 52.2%; p<0.001) were recorded with AF in the presence of CHF more often than in the absence of CHF. The frequency of proper cardiovascular pharmacotherapy was higher, albeit insufficient, in the presence of CHF (64.9%) than in the absence of it (56.1%), but anticoagulants were prescribed less frequently when AF and CHF were combined (38.8% and  49, 0%; p<0.001). The frequency of unreasonable prescription of antiplatelet agents instead of anticoagulants was 52.5% and 33.3% (p<0.001) in the combination of AF, CHF and coronary heart disease, as well as in the combination of AF with coronary heart disease but without CHF. Patients with AF and CHF during the observation period compared with those without CHF had higher mortality from all causes (37.6% and 30.3%; p=0.001), the frequency of non-fatal cerebral stroke (8.2% and 5.4%; p=0.032) and myocardial infarction (4.7% and 2.5%; p=0.036), hospitalizations for CVD (22.8% and 15.5%; p<0.001).Conclusion. Patients with a combination of AF and CHF, compared with the group of patients with AF without CHF, were older, had a higher risk of thromboembolic and hemorrhagic complications, they were more often diagnosed with other concomitant cardiovascular and chronic noncardiac diseases, decreased left ventricular ejection fraction, tachysystole, failure to achieve the target blood pressure level in the presence of arterial hypertension. The frequency of prescribing proper cardiovascular pharmacotherapy was higher, albeit insufficient, in the presence of CHF, while the frequency of prescribing anticoagulants was less. The  incidence of mortality from all causes, the development of non-fatal myocardial infarction   and cerebral stroke, as well as the incidence of hospitalizations for CVDs were higher in AF associated with CHF

The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA

FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis